| Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis CY Kao, BS Sheu, JJ Wu Biomedical journal 39 (1), 14-23, 2016 | 543 | 2016 |
| Impact of supplement with Lactobacillus‐ and Bifidobacterium‐containing yogurt on triple therapy for Helicobacter pylori eradication BS Sheu, JJ Wu, CY Lo, HW Wu, JH Chen, YS Lin, MD Lin Alimentary pharmacology & therapeutics 16 (9), 1669-1675, 2002 | 353 | 2002 |
| Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus JM Liou, P Malfertheiner, YC Lee, BS Sheu, K Sugano, HC Cheng, ... Gut 69 (12), 2093-2112, 2020 | 293 | 2020 |
| Long-term results of anti–Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma LT Chen, JT Lin, JJ Tai, GH Chen, HZ Yeh, SS Yang, HP Wang, SH Kuo, ... Journal of the National Cancer Institute 97 (18), 1345-1353, 2005 | 264 | 2005 |
| Pretreatment with Lactobacillus-and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after … BS Sheu, HC Cheng, AW Kao, ST Wang, YJ Yang, HB Yang, JJ Wu The American journal of clinical nutrition 83 (4), 864-869, 2006 | 230 | 2006 |
| Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus KM Fock, N Talley, KL Goh, K Sugano, P Katelaris, G Holtmann, ... Gut 65 (9), 1402-1415, 2016 | 219 | 2016 |
| The impacts of H. pylori virulence factors on the development of gastroduodenal diseases WL Chang, YC Yeh, BS Sheu Journal of biomedical science 25, 1-9, 2018 | 211 | 2018 |
| Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection BS Sheu, SM Sheu, HB Yang, AH Huang, JJ Wu Gut 52 (7), 927-932, 2003 | 196 | 2003 |
| Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation YJ Chang, MS Wu, JT Lin, BS Sheu, T Muta, H Inoue, CC Chen Molecular pharmacology 66 (6), 1465-1477, 2004 | 178 | 2004 |
| Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFκB pathways YJ Yang, CC Chuang, HB Yang, CC Lu, BS Sheu BMC microbiology 12, 1-8, 2012 | 159 | 2012 |
| Probiotics‐Containing Yogurts Suppress Helicobacter pylori Load and Modify Immune Response and Intestinal Microbiota in the Helicobacter pylori‐Infected … YJ Yang, BS Sheu Helicobacter 17 (4), 297-304, 2012 | 146 | 2012 |
| Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial JM Liou, YJ Fang, CC Chen, MJ Bair, CY Chang, YC Lee, MJ Chen, ... The Lancet 388 (10058), 2355-2365, 2016 | 142 | 2016 |
| Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism BS Sheu, AW Kao, HC Cheng, SF Hunag, TW Chen, CC Lu, JJ Wu Alimentary pharmacology & therapeutics 21 (3), 283-288, 2005 | 121 | 2005 |
| Prevalence of Primary Fluoroquinolone Resistance Among Clinical Isolates of Helicobacter pylori at a University Hospital in Southern Taiwan KH Hung, BS Sheu, WL Chang, HM Wu, CC Liu, JJ Wu Helicobacter 14 (1), 61-65, 2009 | 116 | 2009 |
| Liver volume in patients with or without chronic liver diseases. XZ Lin, YN Sun, YH Liu, BS Sheu, BN Cheng, CY Chen, HM Tsai, ... Hepato-gastroenterology 45 (22), 1069-1074, 1998 | 112 | 1998 |
| Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression IY Kuo, CC Wu, JM Chang, YL Huang, CH Lin, JJ Yan, BS Sheu, PJ Lu, ... International journal of cancer 135 (3), 563-573, 2014 | 110 | 2014 |
| Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen BS Sheu, S Odenbreit, KH Hung, CP Liu, SM Sheu, HB Yang, JJ Wu Official journal of the American College of Gastroenterology| ACG 101 (1), 36-44, 2006 | 109 | 2006 |
| Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment. BS Sheu, CY Lin, XZ Lin, SC Shiesh, HB Yang, CY Chen American Journal of Gastroenterology (Springer Nature) 91 (3), 1996 | 107 | 1996 |
| Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis Y Xiao, S Zhang, N Dai, G Fei, KL Goh, HJ Chun, BS Sheu, CF Chong, ... Gut 69 (2), 224-230, 2020 | 97 | 2020 |
| Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori CH Chi, CY Lin, BS Sheu, HB Yang, AH Huang, JJ Wu Alimentary pharmacology & therapeutics 18 (3), 347-353, 2003 | 97 | 2003 |
Yao-Jong YangDepartment of Pediatrics, National Cheng Kung University HospitalVerified email at mail.ncku.edu.tw
